Yes indeed Flyer. Agree with most . Mithra valuation got to exactly 1b Euros yesterday. This is $1.6 billion Aussie. That just so happens to be exactly half Mayne Pharma valuation 4 years ago. Even with Aussie considerably stronger against US than currently. Afraid I cannot go along with Mithra Balance Sheet at present. Quite a lot of debt. They really need USA approval at FDA for E4 then can expand from contraceptive to Menopause In Women’s Health. It all depends upon cost price of Product ( contraceptive) to Mayne in contract agreement. This is Paramount to Mayne Future. We had to give away 10% of company as we couldn’t raise cash . Too much debt accrued with Teva Debacle.
MYX Price at posting:
37.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)